Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
Futamura, Manabu; Ishihara, Kazuhiro; Nagao, Yasuko; Ogiso, Atsuko; Niwa, Yoshimi; Nakada, Takumi; Kawaguchi, Yoshihiro; Ikawa, Ai; Kumazawa, Iwao; Mori, Ryutaro; Kitazawa, Mai; Hosono, Yoshiki; Kuno, Masashi; Kawajiri, Mana; Nakakami, Akira; Takeuchi, Makoto; Morikawa, Akemi; Tokumaru, Yoshihisa; Katagiri, Yasuo; Asano, Yoshimasa; Mushika, Yoshinori; Shimokawa, Toshio; Matsuhasih, Nobuhisa.
Afiliación
  • Futamura M; Department of Breast Surgery, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan. mfutamur@gifu-u.ac.jp.
  • Ishihara K; Department of Surgery, Gihoku Kosei Hospital, Gifu, 501-2105, Japan.
  • Nagao Y; Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan.
  • Ogiso A; Department of Surgery, Gifu Prefectural General Medical Center, Gifu, Japan.
  • Niwa Y; Department of Breast Surgery, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Nakada T; Department of Breast Surgery, Gifu Municipal Hospital, Gifu, 500-8513, Japan.
  • Kawaguchi Y; Department of Breast Surgery, Asahi University Hospital, Gifu, 500-8523, Japan.
  • Ikawa A; Department of Surgery, Takayama Red Cross Hospital, Takayama, 506-8550, Japan.
  • Kumazawa I; Department of Surgery, Gifu-Seino Medical Center, Ibi Hospital, Ibi, 501-0696, Japan.
  • Mori R; Department of Breast Surgery, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Kitazawa M; Department of Breast Surgery, Asahi University Hospital, Gifu, 500-8523, Japan.
  • Hosono Y; Department of Breast Surgery, Gifu Municipal Hospital, Gifu, 500-8513, Japan.
  • Kuno M; Department of Surgery, Gihoku Kosei Hospital, Gifu, 501-2105, Japan.
  • Kawajiri M; Department of Surgery, Gihoku Kosei Hospital, Gifu, 501-2105, Japan.
  • Nakakami A; Department of Breast Surgery, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Takeuchi M; Department of Breast Surgery, Central Japan International Medical Center, Minokamo, 505-8510, Japan.
  • Morikawa A; Department of Breast Surgery, Central Japan International Medical Center, Minokamo, 505-8510, Japan.
  • Tokumaru Y; Department of Breast Surgery, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194, Japan.
  • Katagiri Y; Department of Pathology, Gifu University Hospital, Gifu, 501-1194, Japan.
  • Asano Y; Department of Surgery, Municipal Ena Hospital, Ena, 509-7201, Japan.
  • Mushika Y; Department of Breast Surgery, Daiyukai General Hospital, Ichinomiya, 491-8551, Japan.
  • Shimokawa T; Clinical Study Support Center, Wakayama Medical University, Wakayama, 614-8509, Japan.
  • Matsuhasih N; Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, 501-1194, Japan.
Breast Cancer ; 30(2): 293-301, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36609911
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Nanopartículas / Neutropenia Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Nanopartículas / Neutropenia Tipo de estudio: Clinical_trials Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón